| 中文名 | 羟基吡格列酮-d4(M-IV) |
|---|---|
| 英文名 | 5-[[2,3,5,6-tetradeuterio-4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione |
| 中文别名 |
羟基吡格列酮D4 (M-IV)
氘4-羟基吡格列酮 [2H4]-羟基吡格列酮 |
| 英文别名 |
Hydroxy Pioglitazone-d4 (M-IV-d4)
[2H4]-Hydroxypioglitazone Leriglitazone-d4 (phenyl-d4) Hydroxy Pioglitazone-d4 5-[(4-{2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy}(2,3,5,H)phenyl)methyl]-1,3-thiazolidine-2,4-dione Phenyl Acetate Impurity 51 Hydroxy Pioglitazone-d4 (M-IV) D4-Hydroxypioglitazone Hydroxy Pioglitazone Labeled d4 Hydroxypioglitazone oxalate salt Hydroxy Pioglitazone D4 ((phenyl-d4) (M-IV) Hydroxy Pioglitazone-d4 (M-IV) (deuterated) Hydroxy Pioglitazone D4 (M-IV)Q: What is Hydroxy Pioglitazone D4 (M-IV) Q: What is the CAS Number of Hydroxy Pioglitazone D4 (M-IV) Q: What is the storage condition of Hydroxy Pioglitazone D4 (M-IV) Q: What e the applications of Hydroxy Pioglitazone D4 (M-IV) N4-Benzoyl-2',3'-dideoxy-3'-monomethoxytritylaminocytidine-5'-O-N,N-diisopropylcyanoethylphosphorami |
| 描述 | Leriglitazone-d4是氘标记的Leriglitazone。利格列酮(羟基吡格列酮),吡格列酮的代谢物。利格列酮(羟基吡格列酮)PioOH是一种PPARγ激动剂,稳定PPARγ激活功能-2(AF-2)共激活物结合表面并增强共激活物结合,提供更好的转录效果。利格列酮(羟基吡格列酮)与Ki为1.2μM的PPARγC端配体结合域(LBD)结合,诱导PPARγ(LBD)的转录效能,EC50为680 nM【1】。 |
|---|---|
| 相关类别 | |
| 体外研究 | 氢、碳和其他元素的稳定重同位素已被纳入药物分子中,主要作为药物开发过程中定量的示踪剂。氘化因其可能影响药物的药代动力学和代谢特征而受到关注[1]。 |
| 参考文献 |
| 分子式 | C19H16D4N2O4S |
|---|---|
| 分子量 | 376.46 |
| 精确质量 | 376.13900 |
| PSA | 117.31000 |
| LogP | 2.92640 |